Follow
Kimberly Kanigel Winner
Kimberly Kanigel Winner
Post-doctoral fellow, University of Colorado School of Medicine, Computational Biosciences Program
Verified email at unm.edu - Homepage
Title
Cited by
Cited by
Year
Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open …
J Guinney, T Wang, TD Laajala, KK Winner, JC Bare, EC Neto, SA Khan, ...
The Lancet Oncology 18 (1), 132-142, 2017
1322017
Ovarian tumor attachment, invasion, and vascularization reflect unique microenvironments in the peritoneum: insights from xenograft and mathematical models
MP Steinkamp, KK Winner, S Davies, C Muller, Y Zhang, RM Hoffman, ...
Frontiers in oncology 3, 97, 2013
522013
Spatial Modeling of Drug Delivery Routes for Treatment of Disseminated Ovarian CancerIntraperitoneal versus Intravenous Drug Delivery for Ovarian Cancer
KRK Winner, MP Steinkamp, RJ Lee, M Swat, CY Muller, ME Moses, ...
Cancer research 76 (6), 1320-1334, 2016
382016
A DREAM challenge to build prediction models for short-term discontinuation of docetaxel in metastatic castration-resistant prostate cancer
F Seyednasrollah, DC Koestler, T Wang, SR Piccolo, R Vega, R Greiner, ...
JCO clinical cancer informatics 1, 1-15, 2017
122017
Prostate Cancer Challenge DREAM Community. Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model …
J Guinney, T Wang, TD Laajala, KK Winner, JC Bare, EC Neto, SA Khan, ...
Lancet Oncol 18 (1), 132-142, 2017
92017
Implementation of The FAIR Data Principles for Exploratory Biomarker Data from Clinical Trials
Data Intelligence, 2021
22021
Abstract B204: a DREAM Challenge to improve prognostic models in patients with metastatic castrate-resistant prostate cancer
J Guinney, T Wang, C Bare, T Norman, B Bot, L Shen, K Winner, S Friend, ...
Molecular Cancer Therapeutics 14 (12_Supplement_2), B204-B204, 2015
12015
A SPATIOTEMPORAL MODEL TO SIMULATE CHEMOTHERAPY REGIMENS FOR HETEROGENEOUS BLADDER CANCER METASTASES TO THE LUNG: Beyond the Abstract
K Kanigel Winner
https://onctoday.com/beyond-the-abstracts/bladder-cancer/37711-a …, 2017
2017
A Spatiotemporal Model to Simulate Chemotherapy Regimens for Heterogeneous Bladder Cancer Metastases to the Lung
KR KANIGEL WINNER, JC Costello
PACIFIC SYMPOSIUM ON BIOCOMPUTING 2017, 611-622, 2017
2017
Use of crowdsourced research to develop a prognostic model for first-line metastatic castrate resistant prostate cancer (mCRPC).
FL Zhou, J Guinney, T Wang, JC Bare, TC Norman, B Bot, L Shen, ...
Journal of Clinical Oncology 34 (2_suppl), 180-180, 2016
2016
A community-based collaboration to build prediction models for short-term discontinuation of docetaxel in metastatic castration-resistant prostate cancer
F Seyednasrollah, DC Koestler, T Wang, SR Piccolo, R Vega, R Greiner, ...
bioRxiv, 087809, 2016
2016
Modeling antibody penetration into metastatic ovarian tumors after intravenous or intraperitoneal delivery
MP Steinkamp, KK Winner, M Moses, Y Jiang, BS Wilson
CLINICAL CANCER RESEARCH 21, 2015
2015
Abstract POSTER-TECH-1124: Modeling antibody penetration into metastatic ovarian tumors after intravenous or intraperitoneal delivery
MP Steinkamp, KK Winner, M Moses, Y Jiang, BS Wilson
Clinical Cancer Research 21 (16_Supplement), POSTER-TECH-1124-POSTER-TECH-1124, 2015
2015
Multi-scale models of ovarian cancer
KK Winner
The University of New Mexico, 2015
2015
Multi-scale models of ovarian cancer
KK Winner
The University of New Mexico, 2015
2015
Ovarian cancer relapse: micro-carcinomas vary in form with peritoneal niche
K Kanigel-Winner, M Steinkamp, S Davies, A Shirinifard, Y Jiang, ...
8th Student Conference, 61, 2012
2012
The system can't perform the operation now. Try again later.
Articles 1–16